Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Zhongyuan Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company operates modern production facilities that comply with Good Manufacturing Practice (GMP) standards, producing a variety of therapeutic products including gastrointestinal medicines, cardiovascular drugs, and antibiotics. Its business model encompasses both domestic sales within China and the export of pharmaceutical products to international markets. Wuhan Zhongyuan Pharmaceutical is recognized for its integrated approach to drug production, from chemical synthesis to final packaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Zhongyuan Pharmaceutical.